What a remarkable year it has been for the Association. We have grown our membership by almost 50%, launched Investors in Healthcare, the official journal of EHIA, and delivered some excellent events across Europe and beyond. We are excited by the future - our reputation, membership and the quality and quantity of what we are able to deliver are all growing - and look forward to developing the association further. Thank you for your support this year. We would like to wish you, your teams, and your families a wonderful Christmas and some down time over the festive season. Sarah Ward Henry Elphick Nick Herbert Alan MacKay Frank Altmeyer
European Healthcare Investor Association (E.H.I.A.)
Financial Services
London, England 6,229 followers
An association of investors, senior managers and advisors focussed on building successful healthcare businesses
About us
European Healthcare Investor Association is the largest association of private capital providers investing in healthcare companies in Europe. Our aim is to provide networking and knowledge opportunities to our members by delivering events and sector focussed market data and analysis, as well as promoting a better understanding of investors’ contribution to the healthcare economy. The Association has over 65 members including private equity, infrastructure and sovereign funds, foundations and family office investors, senior managers, advisors and other members of the healthcare investing community, all focussed on building successful healthcare businesses. E.H.I.A. works in partnership with strategic partners in the advisory community including McKinsey & Company (strategy consulting), J P Morgan (investment banking), McDermott Will & Emery (legal), Compass Carter Osborne (executive search), Marwood Group (regulatory consulting), Knight Frank (real estate), RSM Ebner Stolz (accounting), and Marsh (insurance). Investors in Healthcare, the Official Journal of the Association, is a Google News approved digital business intelligence platform delivering news, data and analytics. This knowledge creates actionable insights for investors, senior managers and advisors in the sector. Access to the journal is included in the membership, with subscriptions available for non-members. www.investorsinhealthcare.com
- Website
-
www.ehia.org
External link for European Healthcare Investor Association (E.H.I.A.)
- Industry
- Financial Services
- Company size
- 1 employee
- Headquarters
- London, England
- Type
- Nonprofit
- Founded
- 2021
- Specialties
- healthcare, privateequity, lifesciences, realestate, investing, news, and data
Locations
-
Primary
Get directions
King's Fund
Cavendish Square
London, England W1G 0AN, GB
Employees at European Healthcare Investor Association (E.H.I.A.)
Updates
-
Level 20 - European Healthcare Investor Association (E.H.I.A.) is proud to partner with Level 20. Read their annual review below. This year we hosted a joint Women in Healthcare Investing event in Paris supported by Investor Member Bridgepoint and Strategic Partner Marwood Group. The event provided an occasion for women across the scope of healthcare investing to network and discuss the market and opportunities and featured a discussion with panellists Anne-Sophie Moinade Director at Bridgepoint, Amandine Ayrem, Partner, Eurazeo Mid-Large Buyout, Hortense Badarani, Managing Director, CVC and Frederikke Beck, Senior Investment Manager, Impilo moderated by Heather Pfeiffer, Director, Healthcare Advisory, Marwood and Lauren Radford Head of Member Services, Level 20. #healthcare #privayecapital #privateequity Gurpreet Manku Rebecca Gibson Fabrice Turcq LEVEL20 FRANCE
Level 20’s Annual Review showcases our activities across Europe and I’m immensely grateful to all our members, committees, supporters, sponsors and the Level 20 team who contribute to our work. Key highlights: > 6,500+ members across 13 European chapters, including expansion into CEE and Belgium over the past two years. Members have access to an online portal and in 2024 we ran or facilitated 134 networking and content/learning events and webinars. > Our mentoring programmes have benefitted 1,300+ mentees over the years. 88% of mentees are still in the industry and 80% of mentees have been promoted at least once (see note for further details). > The second edition of our report on gender diversity in European #privateequity and #venturecapital revealed nearly one in four investors are now women, with continued growth at senior (14%) and mid (26%) levels. The picture across Europe is mixed however and our report provided more context behind the numbers, including actions firms can take to support talented women. We will update this report with data from the Netherlands and the UK in 2025. > We also published research on family leave policies and practice across Europe. We have heard how this dataset and insights are supporting conversations and work at firms and look forward to publishing more market-specific data next year. > Our outreach and advocacy activities also expanded over 2024, including our continued work with GAIN UK. We are excited for the year ahead, including a new careers portal, enhancements to our programmes, updated datasets (including the US), and celebrating our 10th anniversary! For more detail, please read the full Annual Review here: https://lnkd.in/eeYGNHDh If you’re not already a member, you can sign up here (it’s free and open to people working in the industry, including men): https://lnkd.in/eebf4PwU Mentoring note: Aggregated analysis across 1-to-1 mentoring programmes in DACH, France, Italy, Netherlands, Nordics, Spain and the UK, 2015-2022. You can find out more about our mentoring programmes here: https://lnkd.in/eXxVPxEm Level 20 DACH, LEVEL 20 SPAIN Level 20 Ireland LEVEL20 FRANCE Level 20 Netherlands Level 20 Denmark Level 20 Belgium Level 20 CEE Level 20 Finland Level 20 Romania Level 20 Italy
-
Netherlands: Pharma M&A - Investor Member BC Partners has sold portfolio company Synthon for a rumoured €2bn to Goldman Sachs Alternatives. With this transaction, BC Partners has generated around €13bn in proceeds over the past 18 months, delivering approximately €9bn in 2024 alone. READ the full story on Investors in Healthcare here https://lnkd.in/eCTBkjdd Founded in 1991 and headquartered in the Netherlands, Synthon has approximately 1,600 employees and operates four research laboratories and four manufacturing sites located in the Czech Republic, Spain, Chile, and Argentina. The company specialises in developing and manufacturing generic versions of complex drugs. Its portfolio includes treatments for cancer, cardiovascular conditions and multiple sclerosis. Rothschild & Co and Barclays were financial and Latham & Watkins legal advisors to BC Partners and Jefferies and Goldman Sachs were financial and White & Case LLP. A&O Shearman and Sullivan & Cromwell LLP legal. #pharma #lifesciences Julian Hudson Mark Hersee Will Thompson Tommy Erdei Marco Baruzzi Hardik Madlani Anish Mehta Robbie McLaren Eveline Van Keymeulen Dr. Henning C. Schneider
-
Recruitment: Investor Member Novo Holdings is looking for an Assiciate or Senior Associate in Copenhagen. #realassets
Novo Holdings is looking for an Associate or Senior Associate to join our Real Assets investment team in Copenhagen - a part of the Capital Investment division (CI). You will have a central role in the execution of the Novo Holdings’ Real Assets strategy with the aim of continuing the development of an investment portfolio with a balanced risk / return composition as well as strong responsible investment profile.”
Associate or Snr. Associate, Real Asset Investments (Capital Investments) - Novo Holdings
apply.workable.com
-
New Investor Member: Established in 1997, Invision AG is one of the most experienced owner-managed private equity investors headquartered in the DACH region. The firm manages more than EUR 1bn AuM and recently raised its seventh fund. For more than two decades, Invision has a track record of supporting high-quality businesses jointly with the founding families, entrepreneurs, and managers. While Invision is investing across a variety of sectors, healthcare has always been one of the core sectors and still is to date. The current healthcare portfolio consists of LIPOCLINIC Dr. Heck, Vista Alpina, NonStop Gym SA and Careanesth Sarah Ward Nick Herbert Henry Elphick Frank Altmeyer Investors in Healthcare #healthcare #healthcareservices #investing #privateequity
-
-
Just 15 seconds - TAKE THE SURVEY here https://lnkd.in/gMH36V-t As European Healthcare Investor Association (E.H.I.A.) looks to focus on what is most relevant to investors, please let us have your feedback on the topics of most interest to you at the Investors in Healthcare Private Capital Conference 2025 in June 2025. One stream will be life sciences and pharma where our Stream Partner is Marwood Group: #lifesciences #privateequity Sarah Ward Grace Mackintosh Heather Pfeiffer Walt Breakell Nayan Ghosh
-
-
Europe: November news roundup from Investors in Healthcare includes articles on Concept Life Sciences, Charnwood Discovery, Limerston Capital, TA Associates, Nexus AG, Partners Group, Eurofins, SYNLAB España, Rothschild & Co, Resalis Therapeutics, Sanofi, Halozyme, Inc., Evotec, CBPE, HealthNet Homecare (UK) Ltd, The Riverside Company, HTBA (HealthTech BioActives), Miura Partners Register for free, limited access: https://lnkd.in/eAUMfyAc Subscribe for full access: https://lnkd.in/eqG568d9 Subscribe to the email newsletter: https://lnkd.in/epNp47wE #healthcare #lifesciences #pharma #privateequity #investing #news Nick Herbert Sarah Ward Henry Elphick Frank Altmeyer
Investors in Healthcare: November roundup
European Healthcare Investor Association (E.H.I.A.) on LinkedIn
-
STREAM PARTNER ANNOUNCED - Investors in Healthcare European Private Capital conference is delighted to announce EHIA Strategic Partner Marwood Group as the Life Sciences & Pharma Stream Partner 💉 💊 ⚕ The Marwood Group is a healthcare-focused advisory and consulting firm headquartered in New York City with offices in Washington, D.C. and London. With a deep understanding of the influence policy, politics and market dynamics have on reimbursement, regulation, and business performance, Marwood Group supports their client’s investment decisions in assets across Europe and the United States. Marwood provides investors and operators with policy, regulatory, funding and reimbursement analysis, assessing the risk and opportunities that result from government action on the national or local level. A multilingual European team brings years of relevant healthcare expertise to every engagement. SAVE THE DATE 📅 3 June 2025 🌐 London This European Healthcare Investor Association (E.H.I.A.) conference will be a CEO and partner-level event hosted in an elegant townhouse in the heart of London’s Mayfair, providing a private and intimate environment for networking and understanding market trends. One-on-one meetings will be available for all participants. The Life Sciences track will cover selected markets, beginning with our Knowledge Partner presenting insights on market size, growth, participants and drivers/areas of focus for investors. This will be followed by individual company presentations, Q&A sessions, and panel discussions addressing key investor themes. #healthcare #lifesciences #privateequity Sarah Ward Nick Herbert Grace Mackintosh Heather Pfeiffer Walt Breakell Nayan Ghosh
-
-
Pharma Services: Investor Member Inflexion explores the increasingly complex and ever-evolving nature of the pharma services sector. Matthew McCarty, a specialist in advising Life Science Technology businesses and advisor to Inflexion looks at how #Pharmaceuticals companies have long relied on services and firms to support them with innovative products and offerings. In today’s market, the winners will be the providers which can help to optimise #recruitment, streamline operations and overlay hashtag #digital enhancements. VIEW the article here ➡️ https://lnkd.in/eq6x5Rgc #pharmaservices #healthcare Investors in Healthcare
Healthcare Spotlight: Challenges and opportunities for pharma services and healthcare technology businesses within clinical trials
inflexion.com
-
European Healthcare Investor Association (E.H.I.A.) reposted this
Last month, our team of healthcare investors, Julius Hugelshofer, Stefanos S., and Vittoria Stefanello, had the privilege of attending the Jefferies Healthcare Conference, followed by the European Healthcare Investor Association (E.H.I.A.)'s Annual Gala 2024. The discussions and insights exchanged during both events reaffirmed the dynamic nature of the healthcare sector and its evolving opportunities. 🔑 Key Takeaways from the Jefferies Conference: 🌍 Resilience in Valuation Amidst a Tepid M&A Environment Despite a slower-moving M&A landscape, multiples remain strong. Investment committees are maintaining high standards, prioritizing premium assets. Across Europe, the USA, and Asia, the focus is on value creation, fostering optimism and strengthening investor sentiment. 🏥 A Late 2024 Healthcare Services Pickup? While 2024 has seen slower-than-expected activity in healthcare services, conversations suggest an anticipated pickup in the final quarter. This could set the stage for a robust and busy 2025. 🇪🇺 Awaiting Key Exits in Europe European investors, both buyers and sellers, are closely watching for the first few healthcare service exits following a 24-month pause caused by interest rate hikes and inflationary pressures. When these materialize, they could trigger a snowball effect across the sector. 💡 Creative Approaches to Exits With liquidity challenges, investors are exploring innovative exit strategies, including combinations and continuation funds. At Verlinvest, our evergreen structure positions us well to navigate and capitalize on these trends. 🐾💉 Spotlight on Vets and Aesthetics Interestingly, there’s increasing attention on segments like veterinary care and aesthetics—areas that were often overlooked in healthcare conferences just a few years ago. What trends or opportunities are you seeing in the healthcare space? Let us know in the comments! #Verlinvest #HealthcareInnovation #EHIA2024 #ValueCreation #Investing
-